Kidney care raises its ambitions at ASN Kidney Week 2026
Following ASN Kidney Week 2026, pharmaphorum spoke with Hansa Biopharma's Maria Törnsén and Tes Pharma's Andrea Pellacani about the conference.
Newsletters and Deep Dive digital magazine
Following ASN Kidney Week 2026, pharmaphorum spoke with Hansa Biopharma's Maria Törnsén and Tes Pharma's Andrea Pellacani about the conference.
pharmaphorum spoke with Dr Amy Walker, CEO of 4basebio, about personalised cancer vaccines and synthetic DNA.
In oncology, time is not simply a measure of care; it is a clinical variable – and increasingly a therapeutic challenge.
Too often, oncology trials fail for reasons that could have been anticipated and addressed.
As AI adoption increases, it is exposing just how prepared organisations really are to operate in a digitally connected environment.
Editor's Picks
Newsletters and Deep Dive
digital magazine